Tobramycin Solution/ Drops
NDC 85766-189
Product Information
Tobramycin is a ANDA-approved product labeled by Sportpharm Llc. This medication is used to treat eye infections. It is supplied as a white solution/ drops for ophthalmic administration. This product entry covers the primary NDC 85766-189 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 85766-189?
What are the uses of this product?
What are Active Ingredients of this product?
- TOBRAMYCIN 3 mg/mL - An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TOBRAMYCIN (UNII: VZ8RRZ51VK)
- TOBRAMYCIN (UNII: VZ8RRZ51VK) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)
- BORIC ACID (UNII: R57ZHV85D4)
- SODIUM SULFATE ANHYDROUS (UNII: 36KCS0R750)
- TYLOXAPOL (UNII: Y27PUL9H56)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- SULFURIC ACID (UNII: O40UQP6WCF)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 313415 - tobramycin 0.3 % Ophthalmic Solution
- RxCUI: 313415 - tobramycin 3 MG/ML Ophthalmic Solution
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.